Clinical Trials on Non-small Lung Cancer in Netherlands

Total 553 results

Maastricht Radiation Oncology

Completed

Concurrent Chemo-radiation Form NSCLC to a Individualized MLD (BRONC CONC MLD)

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Usefulness of Blood Biomarkers for Overall Survival in NSCLC

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Radiotherapy for NSCLC to a Individualized MLD (BRONC MLD)

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center
AstraZeneca

Completed

Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer (Donan)

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center
Merck KGaA, Darmstadt, Germany

Completed

PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE) (PINNACLE)

Non Small Cell Lung Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (N12HYB)

Inoperable Locally Advanced Non Small Cell Lung Cancer

Netherlands
Hoffmann-La Roche

Completed

An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

Netherlands
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors

Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers

United States, Netherlands
Amsterdam UMC, location VUmc
Boehringer Ingelheim

Recruiting

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer (SHARP)

Advanced Stage Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Withdrawn

DE-CT in Lung Cancer Proton Therapy (DE-CT)

Non Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Maastro...

Completed

Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients. (Metformin)

Non Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology
Merck Sharp & Dohme LLC; Academisch Ziekenhuis Maastricht

Completed

Phase I Cetuximab and Concurrent Radio-chemotherapy

Non-small Cell Lung Cancer

Netherlands
Radboud University Medical Center

Terminated

Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy (IDEAL-VMAT)

Stage III Non-small Cell Lung Cancer | Individualized Radiation Dose Escalation

Netherlands
Maastricht Radiation Oncology
University of Pennsylvania

Completed

State of the Art Photon Therapy Versus Particle Therapy for Small Lung Tumors; a Planning Study Based on a Reference Dataset of Patients (Lung stage I)

Non Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

Stage I-III Non-small Cell Lung Cancer

Netherlands
Frame Pharmaceuticals B.V.
University Medical Center Groningen; Erasmus Medical Center; The Netherlands... and other collaborators

Not yet recruiting

FRAME-001 Personalized Vaccine in NSCLC

Non Small Cell Lung Cancer

Netherlands
Amsterdam UMC, location VUmc
Merck Sharp & Dohme LLC

Unknown

89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer

Non Small Cell Lung Cancer

Netherlands
UMC Utrecht

Unknown

MRI Optimization Study in Stage III NSCLC

Stage III Non-small Cell Lung Cancer

Netherlands
Merck KGaA, Darmstadt, Germany

Completed

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer | Non Small Cell Lung Cancer

Netherlands
University Medical Center Groningen

Recruiting

Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer (VULCAN)

Non Small Cell Lung Cancer Metastatic

Netherlands
Maastricht Radiation Oncology
Anticancer Fund, Belgium; Reliable Cancer Therapies

Terminated

Nitroglycerin in Non-small Cell Lung Cancer (Nitroglycerin)

Non Small Cell Lung Cancer (NSCLC)

Netherlands
Erasmus Medical Center

Recruiting

TEIPP Immunotherapy in Patients With NSCLC (TEIPP)

Non Small Cell Lung Cancer

Netherlands
Erasmus Medical Center

Recruiting

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC (HAMLET)

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Analysis of Treatment Outcome and Toxicity in Non-small Cell Lung Cancer Patients Wither-irradiated to a High Dose for Recurrent Disease

Non-small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology
University Medical Center Groningen; The Netherlands Cancer Institute

Completed

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC (NVALT11)

Non Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical Treatment

Netherlands
Radboud University Medical Center

Completed

Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy

NSCLC | Locally Advanced Non-Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology

Completed

Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Stage IV (Oligo-metastases)

Netherlands
Academisch Ziekenhuis Maastricht
The Netherlands Cancer Institute; ZonMw: The Netherlands Organisation for Health...

Completed

Pharmacokinetic Boosting of Osimertinib (OSIBOOST)

Non Small Cell Lung Cancer

Netherlands
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer

Netherlands, United Kingdom
Genentech, Inc.

Completed

A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

United States, France, Netherlands
Erasmus Medical Center

Recruiting

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) (START-TKI)

Non Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase Inhibitor

Netherlands
Maastricht University Medical Center

Recruiting

Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat (OSIBOOST-2)

Non-small Cell Lung Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered

Non Small Cell Lung Cancer (NSCLC) | Intrathoracic Nodal Staging

Netherlands, Poland
Bayer

Completed

A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Healthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation

Netherlands
Maastricht Radiation Oncology
Universitaire Ziekenhuizen KU Leuven

Completed

Detection of Circulating Biomarkers of Immunogenic Cell Death (ICD)

Non Small Cell Lung Cancer

Netherlands, Belgium
Galvanize Therapeutics, Inc.

Active, not recruiting

Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer (INCITE ES)

Non Small Cell Lung Cancer

Hong Kong, Spain, Netherlands
Dutch Society of Physicians for Pulmonology and...

Completed

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer (NVALT12)

Non Small Cell Lung Cancer

Netherlands
ETOP IBCSG Partners Foundation
Hoffmann-La Roche

Terminated

ALEctinib for the Treatment of Pretreated RET-rearranged Advanced Non-small Cell Lung Cancer (ALERT-lung)

Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Recurrent

Ireland, Spain, Belgium, Italy, Netherlands, Switzerland
Leiden University Medical Center
Jessa Hospital; The Netherlands Cancer Institute

Recruiting

Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy (Prediction)

Immunotherapy | Non Small Cell Lung Cancer Stage III

Netherlands, Belgium
Maastricht Radiation Oncology
Comprehensive Cancer Centre The Netherlands

Withdrawn

Time Trends in Waiting Times of NSCLC Patients.

Non-Small Cell Lung Cancer

Netherlands
Maastricht Radiation Oncology
Maastricht University Medical Center; Zuyderland Medical Centre

Completed

Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth

Stage IV Non-small Cell Lung Cancer

Netherlands
Amsterdam UMC, location VUmc

Recruiting

[18F]F-AraG PET Imaging to Visualize Tumor Infiltrating T-cell Activation in Non-small Cell Lung Cancer. (ATTAIN)

Non-Small Cell Lung Cancer

Netherlands
Free University Medical Center

Unknown

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Netherlands
Genmab

Terminated

Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer

Non Small Cell Lung Cancer

Belgium, United States, France, Netherlands, United Kingdom
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Dose Individualization of Pemetrexed - IMPROVE-III (IMPROVE-III)

Non Small Cell Lung Cancer | Mesothelioma

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Dose Individualization of Pemetrexed - IMPROVE-I (IMPROVE-I)

Non Small Cell Lung Cancer | Mesothelioma

Netherlands
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Terminated

Dose Individualization of Pemetrexed - IMPROVE-II (IMPROVE-II)

Non Small Cell Lung Cancer | Mesothelioma

Netherlands
Radboud University Medical Center
UMC Utrecht; Amsterdam UMC, location VUmc; St. Antonius Hospital; Dijklander Ziekenhuis and other collaborators

Recruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients (NVALT31-PET)

Stage III Non-small Cell Lung Cancer

Netherlands
AstraZeneca

Completed

Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such as Iressa or Tarceva)

Advanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung Cancer

Belgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands

Clinical Trials on Non-small Lung Cancer in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations